{"ticker": {"uuid": "c86662db-2ab0-418e-82f6-6e483e75ab38", "symbol": "42C", "name": "iX Biopharma Ltd.", "exchange": "SES", "country": "SG", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "iX Biopharma Sets July 2026 Expiry for S$0.06 Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOMXg4QnFtM0JPMkFsbkhXYVhDeDJfYVVZbHFzTW5WMnh2V3lqa1dFRkVEZkRkTUxFTE1RcHhpVWtJTVJlOElBdVFyR1Zkdnk1bGJqOHprcXpZbzg1OXVVdUZJclQwTEN1bG1vbU1UWlFnRnJ0dkM0UXFlTnRkYmFwbUdjV2gzc0tGMUZ2TUtUbnlOSmRkM0NadkVqM3JyYnVvS0dSazdVZEc?oc=5", "source_name": "TipRanks", "published_at": "2026-06-20T05:18:59+00:00", "published_display": "20 Jun 2026 05:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Shifts Production Gear to U.S. to Support Wafermine Contract and Growth Push", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPdFBOUlJsV1JTUFBJU0RSR2N3YzJmZ2xqMDBxeW9KNFA0a09ZaXBQUVpyZzBENGNWMVQxNmhSbXlKbTYyRVByd3F5VHJMYnVKZUlhdlJRZk9TaHJiZE43LWZrTTZDSnhaTFhGTHNyUEJsZktWODI1OVJ2YXBxNmg3ZHVnMlF5WEsxMnVZVjBPLXdzTHpaUlFYRXdqTlZkSDFaXzVpSWRVNFVRYjU2czBjRklYcWF5bE9vOF81SEpGNUJ0eXYwVE1PVTV4NXZuVHhrNzZzY2JGcw?oc=5", "source_name": "TipRanks", "published_at": "2026-06-16T09:01:46+00:00", "published_display": "16 Jun 2026 09:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOTF82enFFYjNJY19pTVNRQ2lkZmxnTy1lcjFseXMzdjVtSUN5aXNtQ0x4NGZFZTVUckwtNXlMRVpjX0RhLVF6WmtXMkJiLW9WQmJzekJuMDg4NUpmTUU1eG9MU3NJMjhhSm1tSHd3dzl4cVRwbmpKWEZIN1pMQzR2M1ptQlpvRUtPSGtLSmtJaXh0UTEySFZEZ3J2SE12SVBYeWJ5aS0tSGwwV0ZoOXZXSGZZQVV6MHg5cjNVYlFn?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-16T04:43:16+00:00", "published_display": "16 Jun 2026 04:43", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ix Biopharma (Catalist:42C) Narrowing H1 EPS Loss Challenges Bearish Earnings Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma EGM 2026: Performance Share Vesting Terms for Mr Eddy Lee Yip Hang Explained", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPajNiWGtBZ2pYWDJ5bXloVnJieWR3QVFEUFZMUnlvczNWcXNqU3BsbFg5TXpUajloeGxuSHg4ZUhFeEJfNUVQbHhRQzBvOWpic0VkNmxHUWpqWUVHdVo2UkJaVUtWTEdXTTNNbklURzB6ZWZhTElTRmFYMFhRM0xtNGcwTmQ5RmFpUkdqSnBLcUNaZmxJdjVpTTR5MWhHZXg5TVBCcUhUQWczVXVnTDczVHFHM1pMWGJVSml6djBlTk9rSWVxd25vRQ?oc=5", "source_name": "Minichart", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma\u2019s Lee and wife Tang sell 13 mil shares on two different occasions", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOcE4zN3c1d01IVXZDWHdNZTdLNUQtN1J1MEpFY3lyekpYd0tIX0l4d3E2bzloU0pucUk2TzZGdGZSaG1fU2VlN2Nla2liUmRIVnJoZm80V1QtSGtNY2VQSHFpR1JNOVpINEFVTEhrSTloNkROTEZpUDVKNmc2eW9QMA?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma: Broker Issues Rare 5X Target. How Did It Arrive At That?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNVTlhTC1BYWUtQjlsbnBLS0xycHZ0Qk14SXFiVUxsbXhCMHdLbC16MmJhV2RHTnMyNVgyQ3FQb0o0Yll0cDJQdms3QWRWVDdvV2lZYm1BeFRCUENjUURCWHg0bldGZlpFemNvZWxLeDV3V3FhdE1lZDBLU0RSdnpsYXZLV2JrcUtzTnJ0NmZsNWU5aGw2T0g3SE5LZVppVGZMSzI3Q1V4dGxDZDdVT1EtelJESS1KTFBSa056LWVZY3E2cmgxR3BfQWp2ZnI0UVJ1UFE?oc=5", "source_name": "NextInsight", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma issues 10 mil new ordinary shares at exercise price of six cents each", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOT0tsZVV1bFVZU3JIdkVWek5ka05DV2dBVnVLaXZ5QVM1N2VzdDNnTHpkbkZ6dlZLbUF6RW1zZ0dGUDFfaVlWYnFGZm1tZHRTMmtCbmNySFZnU1RUVGd0djVsYVhGemVCOHdMMjhuTjd0V3c4eWxWMHJ1dHY4UXMtNg?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPTEV5Ml9RbU5iLTVYSGwtZVBmb0xaWGdtcmE1VTVHZXJVbVhBQnZLUHQxQl9jeXhCREc1TXNKaUtWTWZWVFF6SHhGT1g4ZzlVQVhJM1FIdXVweHlNaWhUYVhUVE1jODNKaVJOb1d1VUNSREtZUmNSeS16LS1FcElxeHRaOTAzU0RJZ3pKSlhWbGJoeTdOZ0w5bzlSc291NXRhVkE?oc=5", "source_name": "Singapore Business Review", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Receives SGX Approval for S$6 Million Share Placement and Listing of 75.8 Million New Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQb1hqNWU3UDlHU3JOOHhLNjZ2YzhtN0R6MFVQWUdWZzgtdmN3RC1uX0hmVjJzNEpuYlE4OG5ndmtxN2NRLU9VSE9oMGgzREFEaXpySjdoZnM5UWdjd1otZThPaC1vbjlBVlFhSGt4eHdGci1wM3Ixa2tXQTdvamhONVVQdWpPMnJkNGZsUF9RNm8wbVFXdm9TYWU0NkZYM3lsRF8yaXdsb08ya1VlYWRTR0IteXVHNjd1amhZSkZzY2VLMVpuSS1KRDlyT181RXBoRURQdkVvSV82U1hsdmc?oc=5", "source_name": "Minichart", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Announces S$6 Million Share Placement to Fund U.S. Government Contract Execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOQVF2bGlpVF9FekZtcmxPZVlFcTVVWmxYME9lczlIUFpIWFprcjNEc2Y1X2tubXJ0QWlIWkhmX2xZQlNiVmhqcGZnc2Vmc3pUUDhLbE51WjI4ZHNPUXV5emNmTmYybmVMb0VIZW5rOXFxX1FMTG16QUZYdFRjUzhBelRCLXJYUnY1NmNqZjZBOTZzRS1kWEhPNHZyZElSTV9PQXRfUVRTNTBESk9XZ2F2OHVUWXA0Vkg0d0pKTlJjQlJqVDFjLW1ib1dnZU8?oc=5", "source_name": "Minichart", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOajFjSERHUnYtR3VyVTJ6enJxZFFIYmpFMmczNGhLa1pHRkZ4b1pBcHRwQy01SHpOaGtEdmE0ZUZlWHVIQkhES2dOM2dOYTEzSUpoVzAtU3FNRmhtVWdteXk4bjNvUjZOUi1HMF9STWkyclZyUW0yQmdfclVpejRWRG1xZXhVdXJFM1NOYnplVlFjbkRLdHBIcjZ5QVVHdFFQSElxV3N3?oc=5", "source_name": "Singapore Business Review", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma reports lower net loss for 1HFY2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQRmNtMTdJNFJjcks3aHpoSkJYYzBCTU9QaGZUOUpmQzZWZmdDb3AwMkt6ZVF0U0I3dDVsQXdUWlBTenRXQUR0UW1UTnhUUXdZX1ZTQWN0VVMzRnpFM3VtTXVQQmo0eW5QSTcwWmJQNzZuMjJWdk1TYWJtYU9WVU1sR2xtUUkwUQ?oc=5", "source_name": "Market source", "published_at": "2026-02-08T08:00:00+00:00", "published_display": "08 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Ltd.'s (Catalist:42C) most bullish insider, CEO Yip Hang Lee must be pleased with the recent 15% gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ3FkWG9mSHVvZUFPN0UwdzFHcGhTVmFPTzJ5dkZZQWhJdDRHUXMwQXYwSDR4eUIxUFJXRDlEOGRMMkt4VXpvTWNiMXM5WTZOUUs3S0ZFb1d6LWpyN2pCSWNRMnpxZU1jYURMNFlrdE5zUDloR3dOWkdadnFZQnNsSg?oc=5", "source_name": "Market source", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma to raise at least $5m via OCBC share placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQNkFzUGRWd1ZRTXRxdjd4SHlzaFh5THRBeWh3Ym5Zd2NDTXhYb3JzM1VnQ05OdnNMdE1KZVNKeWJZZzIyOEo2cmdvQVlNMzBvWnVPMzFzVEtDdFVSbGJBLWF1dFlKVWpGRXJZVG9GbHlEdVRTbHZ4aW5mcUZkWG1lakdubjB5QlhadnJKM0dhQQ?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-10-29T07:00:00+00:00", "published_display": "29 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma upsizes placement to raise $6.7m", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxObTdhNFZCU1c5M3gyRlFoclRNcHVWNWVNeWhtbWkxT1FXdFZfRW5tZGJ6eVp3Ukd1OWVQaC1hTVNNenpMaGhsT0F5RU5GX2Y0MEIxRnZXR0xFTXlSQUNuaXdOVjBYeEJKSEN5emI2bm81aDNHY09NMVpzYW4zck5ReWJYbk1oLVFEMlE?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-10-29T07:00:00+00:00", "published_display": "29 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of iX Biopharma Ltd. (SGX:42C)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5uNVp2Q0cwRThleXk3U0F1MVlyX2NGNEhfLUNWZHRuYUNyV051R0FSWVJzSDd1ZlE5cjE2S3Vnd2FvRElnV3diUDU4NWZKZnlRLURlcVVkWktJTXdZQlQ4aV9NcXotdw?oc=5", "source_name": "TradingView", "published_at": "2018-02-08T18:42:31+00:00", "published_display": "08 Feb 2018 18:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "iX Biopharma Sets July 2026 Expiry for S$0.06 Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOMXg4QnFtM0JPMkFsbkhXYVhDeDJfYVVZbHFzTW5WMnh2V3lqa1dFRkVEZkRkTUxFTE1RcHhpVWtJTVJlOElBdVFyR1Zkdnk1bGJqOHprcXpZbzg1OXVVdUZJclQwTEN1bG1vbU1UWlFnRnJ0dkM0UXFlTnRkYmFwbUdjV2gzc0tGMUZ2TUtUbnlOSmRkM0NadkVqM3JyYnVvS0dSazdVZEc?oc=5", "source_name": "TipRanks", "published_at": "2026-06-20T05:18:59+00:00", "published_display": "20 Jun 2026 05:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Shifts Production Gear to U.S. to Support Wafermine Contract and Growth Push", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPdFBOUlJsV1JTUFBJU0RSR2N3YzJmZ2xqMDBxeW9KNFA0a09ZaXBQUVpyZzBENGNWMVQxNmhSbXlKbTYyRVByd3F5VHJMYnVKZUlhdlJRZk9TaHJiZE43LWZrTTZDSnhaTFhGTHNyUEJsZktWODI1OVJ2YXBxNmg3ZHVnMlF5WEsxMnVZVjBPLXdzTHpaUlFYRXdqTlZkSDFaXzVpSWRVNFVRYjU2czBjRklYcWF5bE9vOF81SEpGNUJ0eXYwVE1PVTV4NXZuVHhrNzZzY2JGcw?oc=5", "source_name": "TipRanks", "published_at": "2026-06-16T09:01:46+00:00", "published_display": "16 Jun 2026 09:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOTF82enFFYjNJY19pTVNRQ2lkZmxnTy1lcjFseXMzdjVtSUN5aXNtQ0x4NGZFZTVUckwtNXlMRVpjX0RhLVF6WmtXMkJiLW9WQmJzekJuMDg4NUpmTUU1eG9MU3NJMjhhSm1tSHd3dzl4cVRwbmpKWEZIN1pMQzR2M1ptQlpvRUtPSGtLSmtJaXh0UTEySFZEZ3J2SE12SVBYeWJ5aS0tSGwwV0ZoOXZXSGZZQVV6MHg5cjNVYlFn?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-16T04:43:16+00:00", "published_display": "16 Jun 2026 04:43", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ix Biopharma (Catalist:42C) Narrowing H1 EPS Loss Challenges Bearish Earnings Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma EGM 2026: Performance Share Vesting Terms for Mr Eddy Lee Yip Hang Explained", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPajNiWGtBZ2pYWDJ5bXloVnJieWR3QVFEUFZMUnlvczNWcXNqU3BsbFg5TXpUajloeGxuSHg4ZUhFeEJfNUVQbHhRQzBvOWpic0VkNmxHUWpqWUVHdVo2UkJaVUtWTEdXTTNNbklURzB6ZWZhTElTRmFYMFhRM0xtNGcwTmQ5RmFpUkdqSnBLcUNaZmxJdjVpTTR5MWhHZXg5TVBCcUhUQWczVXVnTDczVHFHM1pMWGJVSml6djBlTk9rSWVxd25vRQ?oc=5", "source_name": "Minichart", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma\u2019s Lee and wife Tang sell 13 mil shares on two different occasions", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOcE4zN3c1d01IVXZDWHdNZTdLNUQtN1J1MEpFY3lyekpYd0tIX0l4d3E2bzloU0pucUk2TzZGdGZSaG1fU2VlN2Nla2liUmRIVnJoZm80V1QtSGtNY2VQSHFpR1JNOVpINEFVTEhrSTloNkROTEZpUDVKNmc2eW9QMA?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma: Broker Issues Rare 5X Target. How Did It Arrive At That?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNVTlhTC1BYWUtQjlsbnBLS0xycHZ0Qk14SXFiVUxsbXhCMHdLbC16MmJhV2RHTnMyNVgyQ3FQb0o0Yll0cDJQdms3QWRWVDdvV2lZYm1BeFRCUENjUURCWHg0bldGZlpFemNvZWxLeDV3V3FhdE1lZDBLU0RSdnpsYXZLV2JrcUtzTnJ0NmZsNWU5aGw2T0g3SE5LZVppVGZMSzI3Q1V4dGxDZDdVT1EtelJESS1KTFBSa056LWVZY3E2cmgxR3BfQWp2ZnI0UVJ1UFE?oc=5", "source_name": "NextInsight", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma issues 10 mil new ordinary shares at exercise price of six cents each", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOT0tsZVV1bFVZU3JIdkVWek5ka05DV2dBVnVLaXZ5QVM1N2VzdDNnTHpkbkZ6dlZLbUF6RW1zZ0dGUDFfaVlWYnFGZm1tZHRTMmtCbmNySFZnU1RUVGd0djVsYVhGemVCOHdMMjhuTjd0V3c4eWxWMHJ1dHY4UXMtNg?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPTEV5Ml9RbU5iLTVYSGwtZVBmb0xaWGdtcmE1VTVHZXJVbVhBQnZLUHQxQl9jeXhCREc1TXNKaUtWTWZWVFF6SHhGT1g4ZzlVQVhJM1FIdXVweHlNaWhUYVhUVE1jODNKaVJOb1d1VUNSREtZUmNSeS16LS1FcElxeHRaOTAzU0RJZ3pKSlhWbGJoeTdOZ0w5bzlSc291NXRhVkE?oc=5", "source_name": "Singapore Business Review", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Receives SGX Approval for S$6 Million Share Placement and Listing of 75.8 Million New Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQb1hqNWU3UDlHU3JOOHhLNjZ2YzhtN0R6MFVQWUdWZzgtdmN3RC1uX0hmVjJzNEpuYlE4OG5ndmtxN2NRLU9VSE9oMGgzREFEaXpySjdoZnM5UWdjd1otZThPaC1vbjlBVlFhSGt4eHdGci1wM3Ixa2tXQTdvamhONVVQdWpPMnJkNGZsUF9RNm8wbVFXdm9TYWU0NkZYM3lsRF8yaXdsb08ya1VlYWRTR0IteXVHNjd1amhZSkZzY2VLMVpuSS1KRDlyT181RXBoRURQdkVvSV82U1hsdmc?oc=5", "source_name": "Minichart", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Announces S$6 Million Share Placement to Fund U.S. Government Contract Execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOQVF2bGlpVF9FekZtcmxPZVlFcTVVWmxYME9lczlIUFpIWFprcjNEc2Y1X2tubXJ0QWlIWkhmX2xZQlNiVmhqcGZnc2Vmc3pUUDhLbE51WjI4ZHNPUXV5emNmTmYybmVMb0VIZW5rOXFxX1FMTG16QUZYdFRjUzhBelRCLXJYUnY1NmNqZjZBOTZzRS1kWEhPNHZyZElSTV9PQXRfUVRTNTBESk9XZ2F2OHVUWXA0Vkg0d0pKTlJjQlJqVDFjLW1ib1dnZU8?oc=5", "source_name": "Minichart", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOajFjSERHUnYtR3VyVTJ6enJxZFFIYmpFMmczNGhLa1pHRkZ4b1pBcHRwQy01SHpOaGtEdmE0ZUZlWHVIQkhES2dOM2dOYTEzSUpoVzAtU3FNRmhtVWdteXk4bjNvUjZOUi1HMF9STWkyclZyUW0yQmdfclVpejRWRG1xZXhVdXJFM1NOYnplVlFjbkRLdHBIcjZ5QVVHdFFQSElxV3N3?oc=5", "source_name": "Singapore Business Review", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma reports lower net loss for 1HFY2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQRmNtMTdJNFJjcks3aHpoSkJYYzBCTU9QaGZUOUpmQzZWZmdDb3AwMkt6ZVF0U0I3dDVsQXdUWlBTenRXQUR0UW1UTnhUUXdZX1ZTQWN0VVMzRnpFM3VtTXVQQmo0eW5QSTcwWmJQNzZuMjJWdk1TYWJtYU9WVU1sR2xtUUkwUQ?oc=5", "source_name": "Market source", "published_at": "2026-02-08T08:00:00+00:00", "published_display": "08 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma Ltd.'s (Catalist:42C) most bullish insider, CEO Yip Hang Lee must be pleased with the recent 15% gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ3FkWG9mSHVvZUFPN0UwdzFHcGhTVmFPTzJ5dkZZQWhJdDRHUXMwQXYwSDR4eUIxUFJXRDlEOGRMMkt4VXpvTWNiMXM5WTZOUUs3S0ZFb1d6LWpyN2pCSWNRMnpxZU1jYURMNFlrdE5zUDloR3dOWkdadnFZQnNsSg?oc=5", "source_name": "Market source", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma to raise at least $5m via OCBC share placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQNkFzUGRWd1ZRTXRxdjd4SHlzaFh5THRBeWh3Ym5Zd2NDTXhYb3JzM1VnQ05OdnNMdE1KZVNKeWJZZzIyOEo2cmdvQVlNMzBvWnVPMzFzVEtDdFVSbGJBLWF1dFlKVWpGRXJZVG9GbHlEdVRTbHZ4aW5mcUZkWG1lakdubjB5QlhadnJKM0dhQQ?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-10-29T07:00:00+00:00", "published_display": "29 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "iX Biopharma upsizes placement to raise $6.7m", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxObTdhNFZCU1c5M3gyRlFoclRNcHVWNWVNeWhtbWkxT1FXdFZfRW5tZGJ6eVp3Ukd1OWVQaC1hTVNNenpMaGhsT0F5RU5GX2Y0MEIxRnZXR0xFTXlSQUNuaXdOVjBYeEJKSEN5emI2bm81aDNHY09NMVpzYW4zck5ReWJYbk1oLVFEMlE?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-10-29T07:00:00+00:00", "published_display": "29 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of iX Biopharma Ltd. (SGX:42C)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5uNVp2Q0cwRThleXk3U0F1MVlyX2NGNEhfLUNWZHRuYUNyV051R0FSWVJzSDd1ZlE5cjE2S3Vnd2FvRElnV3diUDU4NWZKZnlRLURlcVVkWktJTXdZQlQ4aV9NcXotdw?oc=5", "source_name": "TradingView", "published_at": "2018-02-08T18:42:31+00:00", "published_display": "08 Feb 2018 18:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 54, "total_relevant": 17, "sentiment_summary": {"positive": 4, "negative": 5, "neutral": 8, "score": 47, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 0.4, "latest_week": "2026-06-19", "one_week_move": 8.2, "four_week_move": 14.5, "twelve_week_move": 101.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.229992, "market_dynamics_buy_signal": false, "relative_strength": 124.829275, "fair_value_gap": 405.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 46.6612, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+8.2% over one week, +14.5% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 4}, {"label": "Singapore Business Review", "count": 4}, {"label": "Minichart", "count": 3}, {"label": "TipRanks", "count": 2}, {"label": "marketscreener.com", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "NextInsight", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Deals and strategy", "count": 2}, {"label": "Earnings", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "47/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+8.2% over one week, +14.5% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "iX Biopharma Sets July 2026 Expiry for S$0.06 Warrants"}], "updated_at": "2026-06-22T16:28:44.830202+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}